Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis.

MLA

Lee, Kang Nyeong, et al. “Randomized Controlled Trial to Evaluate the Efficacy and Safety of Fexuprazan Compared with Esomeprazole in Erosive Esophagitis.” World Journal of Gastroenterology, vol. 28, no. 44, Nov. 2022, pp. 6294–309. EBSCOhost, https://doi.org/10.3748/wjg.v28.i44.6294.

APA

Lee, K. N., Lee, O. Y., Chun, H. J., Kim, J. I., Kim, S. K., Lee, S. W., Park, K. S., Lee, K. L., Choi, S. C., Jang, J.-Y., Kim, G. H., Sung, I.-K., Park, M. I., Kwon, J. G., Kim, N., Kim, J. J., Lee, S. T., Kim, H. S., Kim, K. B., … Chung, H. (2022). Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis. World Journal of Gastroenterology, 28(44), 6294–6309. https://doi.org/10.3748/wjg.v28.i44.6294

Chicago

Lee, Kang Nyeong, Oh Young Lee, Hoon Jai Chun, Jin Il Kim, Sung Kook Kim, Sang Woo Lee, Kyung Sik Park, et al. 2022. “Randomized Controlled Trial to Evaluate the Efficacy and Safety of Fexuprazan Compared with Esomeprazole in Erosive Esophagitis.” World Journal of Gastroenterology 28 (44): 6294–6309. doi:10.3748/wjg.v28.i44.6294.